NCT04849065RecruitingPhase 2
Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis (TCIM-ELAII)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 8 Oct 2024
- Start date
- 3 May 2021
- Lead sponsor
- Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
- Diseases
- ALS (motor neurone disease)
- NCT number
- NCT04849065
- EU CT number
- 2023-506215-17-00
- EudraCT number
- 2019-002302-46
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 100
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital General Universitario Dr. Balmis Coordinator of this site? Confirm its status | Alicante | Spain | Recruiting |
| University Clinical Hospital Virgen De La Arrixaca Coordinator of this site? Confirm its status | Murcia | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.